Skip to main content

Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • BofA Securities Health Care Conference, Las Vegas

    Fireside chat on Wednesday, May 14, 2025 at 1:40 p.m. ET (10:40 a.m. PT)

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.96
-0.39 (-0.17%)
AAPL  272.44
-1.23 (-0.45%)
AMD  214.12
+0.69 (0.32%)
BAC  55.81
+0.54 (0.99%)
GOOG  310.00
+1.39 (0.45%)
META  659.49
+0.72 (0.11%)
MSFT  485.66
-0.26 (-0.05%)
NVDA  183.46
+2.47 (1.36%)
ORCL  196.42
+4.45 (2.32%)
TSLA  491.75
+10.55 (2.19%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.